|
GB9801392D0
(en)
*
|
1998-01-22 |
1998-03-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9803411D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6194410B1
(en)
*
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
AU5235699A
(en)
*
|
1998-07-31 |
2000-02-21 |
Eli Lilly And Company |
Sulfonamide derivatives
|
|
GB9818914D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
US6586592B2
(en)
|
2000-06-20 |
2003-07-01 |
Pharmacia & Upjohn Company |
Bis-arylsulfones
|
|
PE20020063A1
(es)
|
2000-06-20 |
2002-01-30 |
Upjohn Co |
Bis-arilsulfonas como ligandos del receptor de 5-ht
|
|
US6399617B1
(en)
|
2000-07-21 |
2002-06-04 |
Biovitrum Ab |
Use
|
|
SE0002739D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New use
|
|
GB0021450D0
(en)
*
|
2000-08-31 |
2000-10-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
US7034029B2
(en)
|
2000-11-02 |
2006-04-25 |
Wyeth |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
US6849644B2
(en)
|
2000-11-21 |
2005-02-01 |
Smithkline Beecham P.L.C. |
Isoquinoline derivatives useful in the treatment of CNS disorders
|
|
US7718650B2
(en)
|
2001-05-11 |
2010-05-18 |
Biovitrum Ab |
Aryl sulfonamide compounds for treating obesity
|
|
EP1406884A1
(en)
|
2001-05-11 |
2004-04-14 |
Biovitrum Ab |
Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
|
|
CN1800185A
(zh)
|
2001-06-11 |
2006-07-12 |
比奥维特罗姆股份公司 |
取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ii型糖尿病的药物的应用
|
|
MXPA04001250A
(es)
|
2001-08-10 |
2004-05-27 |
Hoffmann La Roche |
Derivados de arilsulfonilo con afinidad receptora de 5-hidroxitriptamina6 (5-ht6).
|
|
DE60236541D1
(de)
*
|
2001-11-22 |
2010-07-08 |
Biovitrum Ab |
Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
|
|
IL160630A0
(en)
*
|
2001-11-22 |
2004-07-25 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
EA200400707A1
(ru)
|
2001-11-22 |
2004-10-28 |
Биовитрум Аб |
Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
|
|
RS44204A
(sr)
|
2001-11-22 |
2007-06-04 |
Biovitrum Ab., |
Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
|
|
AU2007205749B2
(en)
*
|
2001-11-22 |
2009-04-23 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
ATE323680T1
(de)
*
|
2002-02-13 |
2006-05-15 |
Glaxo Group Ltd |
7-arylsulfonamid-2,3,4,5-tetrahydro-1h- benzo¬däazepine mit 5-ht6 rezeptor affinität zur behandlung von zentralnervensystemerkrankungen
|
|
WO2003068732A2
(en)
*
|
2002-02-13 |
2003-08-21 |
Glaxo Group Limited |
Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
|
|
MXPA04007920A
(es)
*
|
2002-02-13 |
2004-11-26 |
Glaxo Group Ltd |
Derivados de bencensulfonamida como agentes antisicoticos.
|
|
GB0204720D0
(en)
*
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Novel use
|
|
RU2309154C9
(ru)
*
|
2002-03-27 |
2016-09-27 |
Глэксо Груп Лимитед |
3-фенилсульфонил-8-пиперазин-1-ил-хинолины, обладающие аффинностью к 5-нт6 рецептору, способы их получения (варианты)
|
|
PT1506179E
(pt)
|
2002-05-13 |
2006-06-30 |
Hoffmann La Roche |
Derivados de benzoxazina como moduladores de 5-ht6 e suas utilizacoes
|
|
NZ566263A
(en)
*
|
2002-05-24 |
2009-09-25 |
Millennium Pharm Inc |
CCR9 inhibitors and methods of use thereof
|
|
EP1897881A3
(en)
|
2002-06-20 |
2009-03-18 |
Biovitrum AB (publ) |
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
|
JP4754821B2
(ja)
|
2002-06-20 |
2011-08-24 |
プロキシマゲン・リミテッド |
肥満症、ｉｉ型糖尿病およびｃｎｓ障害の治療に有用な新規化合物
|
|
RU2324693C2
(ru)
*
|
2002-10-18 |
2008-05-20 |
Ф.Хоффманн-Ля Рош Аг |
4-пиперазинилбензолсульфонилиндолы, характеризующиеся сродством к рецептору 5-нт6
|
|
KR100874292B1
(ko)
*
|
2002-11-18 |
2008-12-18 |
케모센트릭스 |
아릴 술폰아마이드
|
|
US7227035B2
(en)
*
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
US20070021466A1
(en)
*
|
2002-11-18 |
2007-01-25 |
Solomon Ungashe |
CCR2 inhibitors and methods of use thereof
|
|
US7741519B2
(en)
|
2007-04-23 |
2010-06-22 |
Chemocentryx, Inc. |
Bis-aryl sulfonamides
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
KR100751604B1
(ko)
*
|
2003-03-03 |
2007-08-22 |
에프. 호프만-라 로슈 아게 |
5-ｈｔ6 조절자로서 사용되는 2,5- 및 2,6-치환된테트라하이드로아이소퀴놀린
|
|
TWI289141B
(en)
*
|
2003-03-11 |
2007-11-01 |
Hoffmann La Roche F. Ag. |
Quinolinone derivatives and uses thereof
|
|
GB0305575D0
(en)
*
|
2003-03-11 |
2003-04-16 |
Glaxo Group Ltd |
Novel compounds
|
|
DE602004000260T2
(de)
|
2003-07-22 |
2006-08-24 |
Arena Pharmaceuticals, Inc., San Diego |
Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
US20050201965A1
(en)
*
|
2004-03-11 |
2005-09-15 |
The Procter & Gamble Company |
Personal cleansing compositions
|
|
AU2005245401A1
(en)
*
|
2004-05-12 |
2005-12-01 |
Chemocentryx |
Aryl sulfonamides
|
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
CN102114244A
(zh)
|
2004-09-30 |
2011-07-06 |
弗·哈夫曼-拉罗切有限公司 |
治疗认知障碍的组合物和方法
|
|
EP1695971A1
(en)
*
|
2004-12-30 |
2006-08-30 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted phenyl-piperazine compounds, their preparation and use in medicaments
|
|
AR054044A1
(es)
*
|
2005-05-23 |
2007-05-30 |
Astrazeneca Ab |
Derivados de cromano y tetrahidronaftaleno como moduladores del receptor 5 - ht6; intermediarios en su preparacion; composiciones farmaceuticas que los contienen y su empelo en la fabricacion de medicamentos para el tratamiento de enfermedades del snc y de la obesidad.
|
|
AR054363A1
(es)
*
|
2005-05-23 |
2007-06-20 |
Astrazeneca Ab |
Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
|
|
BRPI0520579B8
(pt)
*
|
2005-08-12 |
2021-05-25 |
Suven Life Sciences Ltd |
composto, processo para a preparação de um composto e composição farmacêutica
|
|
KR101250820B1
(ko)
|
2005-08-16 |
2013-04-04 |
수벤 라이프 사이언시스 리미티드 |
개선된 로사르탄 제조 방법
|
|
EP2316829A1
(en)
|
2005-12-21 |
2011-05-04 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
US20090022684A1
(en)
*
|
2006-05-09 |
2009-01-22 |
Paul Morley |
Methods for hematopoietic stimulation
|
|
MX2009006077A
(es)
|
2007-01-08 |
2009-06-17 |
Suven Life Sciences Ltd |
Compuestos de 5-(heterociclil)alquil-n-(arilsulfonil)indol y su uso como ligandos de la 5-hidroxitriptamina6.
|
|
US20100041672A1
(en)
*
|
2007-03-21 |
2010-02-18 |
Glaxo Group Limited |
Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
|
|
CL2008000986A1
(es)
|
2007-04-06 |
2008-10-17 |
Neurocrine Biosciences Inc |
COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
|
|
EP2155194B1
(en)
|
2007-04-06 |
2015-01-21 |
Neurocrine Biosciences, Inc. |
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
|
|
EA016594B1
(ru)
|
2007-05-03 |
2012-06-29 |
Сувен Лайф Сайенсиз Лимитед |
Производные 1-(аминоалкоксиарилсульфонил)индола в качестве 5-нтлигандов
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
US7964627B2
(en)
|
2007-10-26 |
2011-06-21 |
Suven Life Sciences Limited |
Amino arylsulfonamide compounds and their use as 5-HT6 ligands
|
|
EP2508177A1
(en)
|
2007-12-12 |
2012-10-10 |
Glaxo Group Limited |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
|
|
EP2103596A1
(en)
|
2008-03-18 |
2009-09-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Process for the preparation of N-(phenylethyl) anilines salts and solvates thereof useful as serotonin 5-HT6 antagonists
|
|
US20110021538A1
(en)
|
2008-04-02 |
2011-01-27 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
EP2288345B1
(en)
|
2008-04-18 |
2015-06-10 |
University College Dublin National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
DE102008022221A1
(de)
|
2008-05-06 |
2009-11-12 |
Universität des Saarlandes |
Inhibitoren der humanen Aldosteronsynthase CYP11B2
|
|
CA2737282C
(en)
*
|
2008-09-17 |
2014-03-25 |
Suven Life Sciences Limited |
Aryl sulfonamide amine compounds and their use as 5-ht6 ligands
|
|
US8318725B2
(en)
|
2008-09-17 |
2012-11-27 |
Suven Life Sciences Limited |
Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
|
|
US9126946B2
(en)
|
2008-10-28 |
2015-09-08 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
|
|
UA100192C2
(en)
*
|
2008-11-11 |
2012-11-26 |
УАЙТ ЭлЭлСи |
1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
|
|
WO2010125135A1
(en)
|
2009-04-30 |
2010-11-04 |
Abbott Gmbh & Co. Kg |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
|
|
US8362010B2
(en)
|
2009-04-30 |
2013-01-29 |
Abbott Gmbh & Co. Kg |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
AU2010243585B2
(en)
*
|
2009-04-30 |
2014-08-07 |
AbbVie Deutschland GmbH & Co. KG |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
US8343959B2
(en)
|
2009-04-30 |
2013-01-01 |
Abbott Gmbh & Co. Kg |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
ES2547072T3
(es)
*
|
2009-07-21 |
2015-10-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Heteroaril benzamidas, composiciones y métodos de utilización
|
|
US8541404B2
(en)
|
2009-11-09 |
2013-09-24 |
Elexopharm Gmbh |
Inhibitors of the human aldosterone synthase CYP11B2
|
|
JP5628937B2
(ja)
|
2010-01-05 |
2014-11-19 |
スベン ライフ サイエンシズ リミティド |
５−ｈｔ６受容体リガンドとしてのスルホン化合物
|
|
GB201002563D0
(en)
|
2010-02-15 |
2010-03-31 |
Cambridge Entpr Ltd |
Compounds
|
|
WO2012059432A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
|
WO2013055793A1
(en)
|
2011-10-12 |
2013-04-18 |
University Of Pittsburg-Of The Commonwealth System Of Higher Education |
Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer
|
|
AU2013254657B2
(en)
*
|
2012-04-27 |
2015-12-24 |
Glaxo Group Limited |
Novel compounds
|
|
CA2924527C
(en)
|
2013-09-20 |
2022-07-12 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Compounds for treating prostate cancer
|
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
CN104557664B
(zh)
*
|
2013-10-19 |
2020-01-21 |
广东东阳光药业有限公司 |
芳杂环类衍生物及其在药物上的应用
|
|
CN105636941A
(zh)
*
|
2013-10-25 |
2016-06-01 |
葛兰素史密斯克莱有限责任公司 |
新的化合物
|
|
EP3083588B1
(en)
|
2013-12-20 |
2020-12-09 |
Sunshine Lake Pharma Co., Ltd. |
Aromatic heterocyclic compounds and their application in pharmaceuticals
|
|
US9840482B2
(en)
|
2014-04-19 |
2017-12-12 |
Sunshine Lake Pharma Co., Ltd. |
Sulfonamide derivatives and pharmaceutical applications thereof
|
|
CN105367474A
(zh)
*
|
2014-08-12 |
2016-03-02 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
CN104496987B
(zh)
*
|
2014-12-12 |
2016-03-02 |
广东东阳光药业有限公司 |
取代杂环类化合物及其在药物上的应用
|
|
CN104529866A
(zh)
*
|
2014-12-12 |
2015-04-22 |
广东东阳光药业有限公司 |
吲哚类衍生物及其在药物上的应用
|
|
US10022355B2
(en)
|
2015-06-12 |
2018-07-17 |
Axovant Sciences Gmbh |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder
|
|
BR112018000728A2
(pt)
|
2015-07-15 |
2018-09-04 |
Axovant Sciences Gmbh |
resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo
|
|
HK1257102A1
(zh)
|
2015-08-21 |
2019-10-11 |
Portola Pharmaceuticals, Inc. |
苯基哌嗪前蛋白转化酶枯草杆菌蛋白酶/kexin9型(pcsk9)调节剂及其应用
|
|
EP3337497B1
(en)
|
2015-08-21 |
2023-07-12 |
SRX Cardio, LLC |
Composition and methods of use of novel phenylalanine small organic compounds to directly modulate pcsk9 protein activity
|
|
EP3337564A4
(en)
*
|
2015-08-21 |
2019-01-23 |
Portola Pharmaceuticals, Inc. |
COMPOSITION AND METHOD FOR THE USE OF TETRAHYDROISOCHINOLINE SMALL MOLECULES FOR THE BINDING AND MODULATION OF PCSK9 PROTEIN ACTIVITY
|
|
WO2017147328A1
(en)
|
2016-02-23 |
2017-08-31 |
Portola Pharmaceuticals, Inc. |
Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
|
|
US10980806B2
(en)
|
2016-03-24 |
2021-04-20 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
CN111517963A
(zh)
*
|
2020-06-02 |
2020-08-11 |
杭州福莱蒽特科技有限公司 |
环保型2，6-二氯-4-硝基苯胺的制备方法
|
|
US12115154B2
(en)
|
2020-12-16 |
2024-10-15 |
Srx Cardio, Llc |
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
|